Alternatives and Personalized Approaches to GLP-1 Therapy If depression or mood instability emerges during semaglutide treatment, options include dose reduction, switching to a different GLP-1 medication with different pharmacokinetics, or temporarily pausing therapy while addressing the underlying mood disorder with psychiatric support
Mounjaro, a dual GLP-1 and GIP receptor agonist licensed in the UK for type 2 diabetes mellitus, commonly affects gastrointestinal function during initial therapy
Almby KE, Abrahamsson N, Lundqvist MH, Hammar U, Thombare K, Panagiotou A, et al
Presented by CECILE MACE Watch the discussion: #Regulation #Diabetes #Insulin To view or add a comment, sign in If your strategy is 100% flower, youre missing 40% of the conversation
If your goal is not just to train harder today but to build a foundation that lasts for years, cycles like this are where science and strategy meet.